These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1347536)

  • 41. [Mode of action of hypoglycemic sulfanilamides].
    Girardin E; Conte Devolx B
    Therapie; 1991; 46(4):311-4. PubMed ID: 1948807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Insulin treatment of Type II diabetes].
    Berger W; Waeber C; Tatti V
    Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1233-6. PubMed ID: 2237054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin: either alone or combined with oral hypoglycemic agents.
    Firth RG
    Prim Care; 1988 Sep; 15(3):665-83. PubMed ID: 3054969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin and oral hypoglycemic agents.
    Price MJ
    Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
    [No Abstract]   [Full Text] [Related]  

  • 45. Hepatic sensitivity to insulin: effects of sulfonylurea drugs.
    Del Prato S; Vigili de Kreutzenberg S; Riccio A; Tiengo A
    Am J Med; 1991 Jun; 90(6A):29S-36S. PubMed ID: 1872301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The management of non-insulin-dependent diabetes mellitus in the elderly.
    Ruoff G
    J Fam Pract; 1993 Mar; 36(3):329-35. PubMed ID: 8454981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploring the role of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus.
    Graham JP; Stam D
    Pharm Pract Manag Q; 1997 Oct; 17(3):1-9. PubMed ID: 10173306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM.
    Karam JH; Sanz N; Salamon E; Nolte MS
    Diabetes; 1986 Dec; 35(12):1314-20. PubMed ID: 3533680
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does insulin preserve beta-cell function in type 2 diabetes?
    Heise T; Sawicki PT
    J Intern Med; 2002 Apr; 251(4):283-5. PubMed ID: 11952878
    [No Abstract]   [Full Text] [Related]  

  • 50. [Molecular mechanism of action of sulfonylureas].
    Ammon HP
    Dtsch Med Wochenschr; 1988 May; 113(21):864-70. PubMed ID: 3286184
    [No Abstract]   [Full Text] [Related]  

  • 51. Can thiazolidinediones delay disease progression in type 2 diabetes?
    Leiter LA
    Curr Med Res Opin; 2006 Jun; 22(6):1193-201. PubMed ID: 16846552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral sulfonylureas for the treatment of type II diabetes: an update.
    Shank WA; Morrison AD
    South Med J; 1986 Mar; 79(3):337-43. PubMed ID: 3082015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Type II diabetic subjects with secondary failure: treatment with prebreakfast mixed ultralente and regular insulin with a sulfonylurea.
    Kabadi UM; Kabadi MU
    J Fam Pract; 1991 Oct; 33(4):349-53. PubMed ID: 1919450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Insulin monotherapy in patients with diabetes mellitus type 2 developing secondary resistance to sulfanilamide preparations].
    Gendeleka GF
    Lik Sprava; 2000 Mar; (2):72-4. PubMed ID: 10862482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined therapy with a sulfonylurea plus evening insulin: safe, reliable, and becoming routine.
    Riddle MC
    Horm Metab Res; 1996 Sep; 28(9):430-3. PubMed ID: 8911978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [40 years of using sulfonylurea derivatives for treatment of diabetes].
    Sieradzki J
    Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.
    Mevorach M; Giacca A; Aharon Y; Hawkins M; Shamoon H; Rossetti L
    J Clin Invest; 1998 Aug; 102(4):744-53. PubMed ID: 9710443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus.
    Sonnenberg GE; Garg DC; Weidler DJ; Dixon RM; Jaber LA; Bowen AJ; DeChemey GS; Mullican WS; Stonesifer LD
    Ann Pharmacother; 1997 Jun; 31(6):671-6. PubMed ID: 9184703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacologic treatment options for non-insulin-dependent diabetes mellitus.
    Tan GH; Nelson RL
    Mayo Clin Proc; 1996 Aug; 71(8):763-8. PubMed ID: 8691897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Different clinical patterns of secondary drug failure in diabetes mellitus type II patients and their significance for diagnosis of secondary sulfonamide resistance].
    Gendeleka GF
    Lik Sprava; 2001; (3):158-9. PubMed ID: 11560011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.